IMIS

Publications | Institutes | Persons | Datasets | Projects | Maps
[ report an error in this record ]basket (0): add | show Print this page

New conotoxin SO-3 targeting N-type voltage-sensitive calcium channels
Wen, L.; Yang, S.; Zhou, W.; Zhang, Y.; Huang, P. (2006). New conotoxin SO-3 targeting N-type voltage-sensitive calcium channels. Mar. Drugs 4(3): 215-227. https://dx.doi.org/10.3390/md403215
In: Marine Drugs. Molecular Diversity Preservation International (MDPI): Basel. ISSN 1660-3397; e-ISSN 1660-3397, more
Peer reviewed article  

Available in  Authors 

Keywords
    Materials > Hazardous materials > Biological poisons > Neurotoxins
    Pain
    Symptoms > Pain
    Marine/Coastal

Authors  Top 
  • Wen, L.
  • Yang, S.
  • Zhou, W.
  • Zhang, Y.
  • Huang, P.

Abstract
    Selective blockers of the N-type voltage-sensitive calcium (CaV) channels are useful in the management of severe chronic pain. Here, the structure and function characteristics of a novel N-type CaV channel blocker, SO-3, are reviewed. SO-3 is a 25-amino acid conopeptide originally derived from the venom of Conus striatus, and contains the same 4-loop, 6-cysteine framework (C-C-CC-C-C) as O-superfamily conotoxins. The synthetic SO-3 has high analgesic activity similar to ω-conotoxin MVIIA (MVIIA), a selective N-type CaV channel blocker approved in the USA and Europe for the alleviation of persistent pain states. In electrophysiological studies, SO-3 shows more selectivity towards the N-type CaV channels than MVIIA. The dissimilarity between SO-3 and MVIIA in the primary and tertiary structures is further discussed in an attempt to illustrate the difference in selectivity of SO-3 and MVIIA towards N-type CaV channels.

All data in the Integrated Marine Information System (IMIS) is subject to the VLIZ privacy policy Top | Authors